Sponsor

Edwards Lifesciences

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Edwards Lifesciences appears in 19 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials19
Recruiting shown3
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

19 shown
Early Feasibility Study of the Edwards APTURE Transcatheter Shunt SystemNCT07858799 · lead sponsor · 2026-10-01
RECRUITING
Early Feasibility Study - Edwards APTURE Transcatheter Shunt SystemNCT03523416 · lead sponsor · 2018-07-31
RECRUITING
ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt SystemNCT05686317 · lead sponsor · 2023-04-01
ACTIVE_NOT_RECRUITING
TRISCEND II Pivotal TrialNCT04482062 · lead sponsor · 2021-04-09
ACTIVE_NOT_RECRUITING
ExplorATory Study oF the EdWards Transcatheter Atrial Shunt System (AlT FloW Germany)NCT04965623 · lead sponsor · 2021-02-22
WITHDRAWN
Exploratory Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW Canada)NCT04000607 · lead sponsor · 2019-07-10
ACTIVE_NOT_RECRUITING
PARTNER 3 Trial - Mitral Valve in ValveNCT03193801 · lead sponsor · 2018-02-01
ACTIVE_NOT_RECRUITING
Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)NCT03016975 · lead sponsor · 2017-06-01
TERMINATED
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)NCT01757665 · lead sponsor · 2012-12-11
COMPLETED
Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000NCT01651052 · lead sponsor · 2011-07-01
COMPLETED
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFXNCT01171625 · lead sponsor · 2007-10-01
COMPLETED
Magna® Mitral Pericardial Bioprostheses Post-Approval Study ProtocolNCT00853632 · lead sponsor · 2007-08-01
COMPLETED
The ReTAVI Prospective Observational RegistryNCT05601453 · collaborator · 2023-09-05
RECRUITING
Early Discharge After Mitral and Tricuspid Edge-to-edge Repair: an Assessment of Feasibility and SafetyNCT06343363 · collaborator · 2023-05-01
COMPLETED
Paceport Swan-Ganz Data Collection StudyNCT04782154 · collaborator · 2021-08-09
COMPLETED
Right Ventricular Pressure Waveform Monitoring in Cardiac SurgeryNCT04092855 · collaborator · 2018-12-10
UNKNOWN
Treatment of Severe Secondary TRIcuspid Regurgitation in Patients With Advance Heart Failure With CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL)NCT02387697 · collaborator · 2015-01-01
TERMINATED
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative TherapyNCT00526331 · collaborator · 2007-08-01
COMPLETED
Effects of Mitral Valve Repair With the Geoform Ring on CardiomyopathyNCT00428103 · collaborator · 2006-10-01
WITHDRAWN

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Edwards Lifesciences as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor12
collaborator7
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.